SOLVAC S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104 EUR | +0.97% |
|
-0.95% | -16.80% |
| Mar. 20 | Solvay: share price advances, DME Capital strengthens further | CF |
| 2023 | Italian prosecutors ask to drop Solvay licence case against ex-minister | RE |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,736 | 2,362 | 2,544 | 2,405 | 2,330 | 2,159 |
| Enterprise Value (EV) 1 | 2,927 | 2,553 | 2,734 | 2,606 | 2,530 | 2,356 |
| P/E ratio | 8.34 x | 8.91 x | 79.5 x | -7.71 x | 7.95 x | 3.63 x |
| Yield | 3.92% | 4.72% | 4.57% | 4.84% | 4.99% | 5.52% |
| Capitalization / Revenue | 8.19 x | 8.75 x | 68.7 x | -7.91 x | 7.82 x | 3.6 x |
| EV / Revenue | 8.76 x | 9.46 x | 73.9 x | -8.57 x | 8.49 x | 3.93 x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / FCF | 14.3 x | 15.5 x | 152 x | -13.3 x | 13.8 x | 6.35 x |
| FCF Yield | 6.99% | 6.45% | 0.66% | -7.52% | 7.24% | 15.8% |
| Price to Book | 1.08 x | 0.87 x | 0.97 x | 1.26 x | 0.98 x | 0.73 x |
| Nbr of stocks (in thousands) | 21,375 | 21,375 | 21,375 | 21,375 | 21,375 | 21,375 |
| Reference price 2 | 128.0 | 110.5 | 119.0 | 112.5 | 109.0 | 101.0 |
| Announcement Date | 4/6/18 | 4/12/19 | 4/1/20 | 4/1/21 | 4/1/22 | 3/31/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 334 | 270 | 37 | -304 | 298 | 599 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | 333 | 269 | 36 | -308 | 296 | 597 |
| Operating Margin | 99.7% | 99.63% | 97.3% | 101.32% | 99.33% | 99.67% |
| Earnings before Tax (EBT) 1 | 328 | 265 | 32 | -312 | 293 | 594 |
| Net income 1 | 328 | 265 | 32 | -312 | 293 | 594 |
| Net margin | 98.2% | 98.15% | 86.49% | 102.63% | 98.32% | 99.17% |
| EPS 2 | 15.35 | 12.40 | 1.497 | -14.60 | 13.71 | 27.79 |
| Free Cash Flow 1 | 204.6 | 164.6 | 18 | -196 | 183.1 | 371.2 |
| FCF margin | 61.26% | 60.97% | 48.65% | 64.47% | 61.45% | 61.98% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | 62.39% | 62.12% | 56.25% | - | 62.5% | 62.5% |
| Dividend per Share 2 | 5.020 | 5.220 | 5.440 | 5.440 | 5.440 | 5.580 |
| Announcement Date | 4/6/18 | 4/12/19 | 4/1/20 | 4/1/21 | 4/1/22 | 3/31/23 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 191 | 191 | 190 | 201 | 200 | 197 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 205 | 165 | 18 | -196 | 183 | 371 |
| ROE (net income / shareholders' equity) | 10.2% | 7.9% | 0.96% | -11.1% | 10.9% | 18.5% |
| ROA (Net income/ Total Assets) | 6.06% | 4.72% | 0.64% | -6.36% | 6.37% | 10.9% |
| Assets 1 | 5,410 | 5,615 | 5,039 | 4,904 | 4,602 | 5,468 |
| Book Value Per Share 2 | 119.0 | 127.0 | 123.0 | 89.20 | 111.0 | 139.0 |
| Cash Flow per Share | - | 0.0500 | - | - | - | 0.0500 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 4/6/18 | 4/12/19 | 4/1/20 | 4/1/21 | 4/1/22 | 3/31/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
104
EUR
Average target price
150.8
EUR
Spread / Average Target
+44.95%
| 1st Jan change | Capi. | |
|---|---|---|
| -16.80% | 2.37B | |
| -0.19% | 74.89B | |
| +0.09% | 46.52B | |
| -4.19% | 30.82B | |
| +9.85% | 18.19B | |
| -10.05% | 11.54B | |
| -8.09% | 9.73B | |
| +2.79% | 9.4B | |
| +6.35% | 9.37B | |
| +3.85% | 8.11B |
- Stock Market
- Equities
- SOLV Stock
- Financials Solvac S.A.
